𝔖 Bobbio Scriptorium

✦ LIBER ✦

Michael Eric Dyson's Chapel Hill Commencement Address

Book ID: 124614519
Publisher: CH II Publishers
Year: 1997
Weight: 197 KB
Volume: 15
Category: Article
ISSN: 2326-6023
DOI: 10.2307/2962664

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Cost analysis of robotic

Commentary on “Cost analysis of robotic vs. open radical cystectomy for bladder cancer”: Angela Smith, Raj Kurpad, Anjana Lal, Matthew E. Nielsen, Eric M. Wallen, Raj S. Pruthi, Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC

✍ Christopher J. Kane 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Commentary on “Prospective randomized co

Commentary on “Prospective randomized controlled trial of robotic vs. open radical cystectomy for bladder cancer: Perioperative and pathologic results”: Jeff Nix, Angela Smith, Raj Kurpad, Matthew E. Nielsen, Eric M. Wallen, Raj S. Pruthi, Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC

✍ Sean P. Stroup; Christopher J. Kane 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Secrets of Victory: The Office of Censor

Secrets of Victory: The Office of Censorship and the American Press and Radio in World War II by Michael S. Sweeney. Chapel Hill: University of North Carolina Press, 2001. 274 pp

✍ Tracy, James F. 📂 Article 📅 2002 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 187 KB

Roadmap for the development of the Unive

Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database—UNC GOLD

✍ Gallagher, Sarah A.; Smith, Angela B.; Matthews, Jonathan E.; Potter, Clarence W 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 400 KB

Hepatitis C in adults and adolescents wi

Hepatitis C in adults and adolescents with inherited coagulation disorders in the United States: results of a randomized, multicenter trial of combination therapy (interferon α-2B + ribavirin): Michael W Fried, University of North Carolina, Chapel Hill, Chapel Hill, NC; Joy Peter, Emory University, Atlanta, GA; Keith Hoots, University of Texas, Houston, TX; Paul Gaglio, Tulane University, New Orleans, LA; D Talbut, NW Ohio Hemophilia Center, Toledo, OH; P Davis, Children's Healthcare, Atlanta, GA; Fred Rickles, George Washington University Hospital, Washington, DC; Thomas Abshire, Emory University, Atlanta, GA; Hemophilia Hepatitis Therapy Group, University of North Carolina, Chapel Hill, NC

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Protective antibody levels and dose requ

Protective antibody levels and dose requirements of IV 5% Nabi hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B induced end stage liver disease: Rolland C Dickson, Mayo Clinic Jacksonville, Jacksonville, FL; Nora Terrault, University of California at San Francisco, San Francisco, CA; Michael B Ishitani, Mayo Clinic Rochester, Rochester, MN; Rajender Reddy, University of Miami, Miami, FL; Patricia Sheiner, Mt Sinai, New York, NY; Velimir Luketic, Medical College of Virginia, Richmond, VA; Terrence Angtuaco, Rush Presbyterian-St Lukes Medical Center, Chicao, IL; Consuelo Soldevilla-Pico, University of Florida, Gainesville, FL; Michael W Fried, University of North Carolina, Chapel Hill, NC; Robert Brown Jr., Columbia Presbyterian Medical Center, New York, NY; Anna S Lok, University of Michigan, Ann Arbor, MI; Janet Johnson, Nabi, Rockville, MD

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB